Fennec Provides Business Update and Announces Fiscal Year 2019 Financial Results Read more about Fennec Provides Business Update and Announces Fiscal Year 2019 Financial Results
Fennec Pharmaceuticals Completes Rolling Submission of New Drug Application (NDA) to U.S. Food and Drug Administration for PEDMARK™ and Also Submits Marketing Authorization Application (MAA) to European Medicines Agency Read more about Fennec Pharmaceuticals Completes Rolling Submission of New Drug Application (NDA) to U.S. Food and Drug Administration for PEDMARK™ and Also Submits Marketing Authorization Application (MAA) to European Medicines Agency
Fennec Provides Business Update and Announces Third Quarter 2019 Financial Results Read more about Fennec Provides Business Update and Announces Third Quarter 2019 Financial Results
Fennec to Present at the 2019 Cantor Global Healthcare Conference on October 4, 2019 Read more about Fennec to Present at the 2019 Cantor Global Healthcare Conference on October 4, 2019
Fennec Appoints Jodi A. Cook, PhD to Its Board of Directors Read more about Fennec Appoints Jodi A. Cook, PhD to Its Board of Directors
Fennec Appoints Shubh Goel as Chief Commercial Officer Read more about Fennec Appoints Shubh Goel as Chief Commercial Officer
Fennec Provides Business Update and Announces Second Quarter 2019 Financial Results Read more about Fennec Provides Business Update and Announces Second Quarter 2019 Financial Results
Fennec Announces Results of Annual Meeting Read more about Fennec Announces Results of Annual Meeting
Fennec Provides Business Update and Announces First Quarter 2019 Financial Results Read more about Fennec Provides Business Update and Announces First Quarter 2019 Financial Results
Fennec Provides Business Update and Announces Fiscal Year 2018 Financial Results Read more about Fennec Provides Business Update and Announces Fiscal Year 2018 Financial Results
